Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 864 participants.
Also called NCT07476898
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 864 participants
- Registry
-
NCT07476898
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07476898. Randomized; no masking; primary purpose treatment. Start 2026-03-01 (anticipated); primary completion 2028-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window
- Acronym
- TIME-MINOR
- Condition
- Stroke
- Intervention (Drug)
- Tenecteplase (0.25mg/kg)
- Intervention (Drug)
- Standard Medical Management
- Lead sponsor
- First Hospital of China Medical University
Record details
- Record id
cardio:ct-nct07476898- Content hash
aef02ab8859a90412a4e376e11d255fd970d446b16d5f7f3acbf1ac340faa809